Norwich Clinical Services - NCS

Norwich Clinical Services - NCS is a global Contract Research Organization (CRO) headquartered in Bangalore, India. Founded in 2010, it provides Clinical Research, Bioanalytical, Pharmacovigilance, and Training Services, with a leadership team possessing deep insight, knowledge, and experience.

The company's Pharmacovigilance team manages >750 Molecules for the US, Europe, and APAC, with call centers in the US and India. NCS has state-of-the-art facilities and expertise in conducting Phase I, II, and III studies, bioavailability and bioequivalence studies, pharmacokinetic studies, and clinical developmental programs. It also has experience in various dosage forms and is dedicated to exceeding customer requirements.

NCS has received inspections from global regulatory agencies such as FDA, WHO, ANVISA, MOH Turkey, EMA, DCGI, and NPRA and operates in strict adherence to GCP, GLP and 21 CFR (part 11) guidelines. As a Lotus Pharmaceuticals Company, their mission statement emphasizes a commitment to maximizing customer satisfaction and delivering high-quality projects meeting regulatory requirements.

Overall, Norwich Clinical Services offers a complete range of Clinical, Bioanalytical, Pharmacovigilance, and Training Services with a focus on excellence and continuous improvement. Despite lacking recent investment information, the company's strong positioning in the Health Care industry and its comprehensive service offerings make it an intriguing prospect for potential investors.